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Abstract
 .Molecular mechanisms leading to elevated calmodulin CaM expression in cancer have not yet been discovered. We
have quantitated the levels of transcripts derived from all three CaM genes in a variety of the same origin rat fibroblasts
transformed with oncogenes in combination with gene for protein kinase C using Northern blot analysis with three CaM
gene specific cDNA probes. Five species of CaM mRNA were detected in all these cells. Surprisingly many of the
investigated cell lines exhibited a decreased content of all CaM mRNAs as compared to control cells with CaMI and CaMII
transcripts showing the most pronounced alterations. In contrast, CaM protein levels were increased in all these cell lines as
determined by a radioimmunoassay. These results suggest that oncogenic up-regulation of CaM synthesis takes place
posttranscriptionally. Several CaM binding proteins were found at different concentrations in the studied cell lines
depending on the oncogenes used for transformation. However, CaM overexpression does not seem to affect the overall
levels of CaM binding proteins. q 1997 Elsevier Science B.V.
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1. Introduction
 .Calmodulin CaM is a highly conserved protein
belonging to the EF-hand family of Ca2q-binding
proteins and is found in all eukaryotic cells at varying
w xconcentration 1,2 . CaM modulates the activities of
several key enzymes and cellular processes including
regulation of cell growth, division, differentiation and
w xcell death 3,4 . The involvement of CaM in the
) Corresponding author. Institute of Molecular Biology,
Farimagsgade 2A, DK-1353 Copenhagen K, Denmark. Fax: q45
33 935220.
1 Present address: Institute of Molecular Biology, University of
Copenhagen.
regulation of cellular proliferation is of particular
interest because cell cycle progression and cell trans-
formation are accompanied by characteristic alter-
ations in cell morphology, cyclic nucleotide
metabolism, metabolic rate and intracellular calcium
levels, processes which are all considered to be influ-
enced by Ca2q ions. The function of CaM is medi-
ated by its Ca2q-dependent or independent associa-
w x 2qtion to specific CaM target proteins 5,6 . Ca rCaM
dependent activation of these proteins is clearly a
response to a variety of hormones, neurotransmitters
and drugs that through receptor interaction provoke
increased intracellular Ca2q. Thus, it becomes impor-
tant to identify CaM binding proteins in order to
understand the mechanisms involved in the functions
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of CaM in cellular activities. In vertebrates CaM is
encoded by three different genes: CaMI, CaMII and
w xCaMIII 2,7–10 . Multiple mRNA species for CaM
were detected in rat and human tissues and are now
known to arise from three legitimate genes. All mR-
NAs produce the same small monomeric protein
 .molecular weight 17,000 dalton consisting of 148
amino acids and four Ca2q-binding domains.
In cells transformed by either oncogenic viruses,
chemical carcinogens or hormone treatments, the level
w xof CaM is generally increased 11–13 . This increase
is believed to be the result of an enhanced rate of
CaM synthesis. A recent study has shown that the
levels of CaM and DNA synthesis in human lung
w xcancer were increased 14 . A molecular link of how
CaM may regulate growth and cell cycle progression
is indicated by the fact that several transcription
factors such as the cAMP response element binding
 .protein CREB and the glucocorticoid hormone re-
ceptor are phosphorylated and thereby activated by
2q w xCa rCaM kinases 15,16 . However, the molecular
mechanisms by which CaM influences cell growth in
normal and transformed cells and how the CaM
genes are regulated are not well known.
 .Protein kinase C PKC is one of the major media-
tors of signals generated upon external stimulation of
cells by hormones, neurotransmitters and growth fac-
w xtors 17 . In the nucleus, certain oncoproteins appear
to function as ultimate vectors of PKC-dependent
signalling pathways, or to cooperate with other
PKC-regulated nuclear proteins in altering gene ex-
pression. The transcription factors c-fos, c-jun, and
c-myc have been implicated in PKC action because
they are rapidly induced by a variety of growth
factors and synthetic compounds, including the known
PKC activator 12-0-tetradecanoylphorbol-13-acetate
 .TPA . These reagents activate the expression of
several genes that carry the TPA response element
which recognises fos-jun heterodimers or jun-jun ho-
modimer as part of the AP-1 transcription factor
complex. These various gene products may therefore
provide a crucial link between signals at the cell
surface, PKC activation, and the control of gene
expression, growth and differentiation. A crosstalk
between the PKC and the Ca2qrCaM signalling sys-
tem could be predicted at the level of Ca2q itself or
2q of common substrates for Ca rCaM and PKC e.g.,
.transcription factors . Since PKC activity is linked to
growth regulation, it is of interest to know whether
the Ca2qrCaM signalling system is affected by over-
expression of PKC and the various oncogenes.
In order to obtain more information about the role
of CaM and CaM binding proteins in normal and
transformed cells, we determined the levels of tran-
scripts derived from the three CaM genes and the
changes in CaM and CaM binding proteins in rat
embryo fibroblast cells stably transfected with PKCb I
and different oncogenes as well as combinations of
them.
2. Materials and methods
2.1. Materials
 .Dulbecco’s Modified Eagles Medium DMEM
 .was obtained from GibcoBRL, Basel, Switzerland ,
 .foetal calf serum FCS , gentamycin and trypsin from
 .AMIMED, Basel, Switzerland ; Biodyne A mem-
 .branes were from Pall New York, USA ; Calmod-
w125 xulin I RIA kit from New England Nuclear
 .DuPont, Regensdorf, Switzerland ; Sephadex G-50
 .from Pharmacia Uppsala, Sweden ; Geneticin G418
from Gibco BRL; the three rat CaM gene specific
cDNA probes were kindly provided by Dr. Nojima
 .Osaka, Japan . All other reagents were from Fluka
 .Buchs, Switzerland .
Cells: R6-C1 and R6-src, R6-PKC, R6-PKC src,
R6-myc, R6-PKC myc3, R6-neuT, R6-neuN, R6-PKC
fos3, R6-PKC fos4, R6-T24 ras, R6-PKC T24 ras
 .and R6-PKC myc cs have been described by Borner
w x w xet al. 18 and Hsiao et al. 19 .
2.2. Cell culture
Both normal and transformed rat fibroblasts were
maintained in DMEM supplemented with 10% FCS
and 50 mgrml gentamycin and incubated in a humid-
ified atmosphere of 5% CO at 378C. In addition, all2
transformed rat fibroblasts containing the PKC gene
were maintained in 50 mgrml geneticin G418. The
medium was changed every 3 days. Starving of the
cultures and growth to postconfluence were strictly
avoided. The cells were harvested for RNA and
protein isolation when they were subconfluent.
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2.3. RNA isolation
Trypsinised cells were centrifuged at 500=g for
5 min at 48C and washed three times with cold
 .phosphate buffered saline PBS . Cell pellets were
stored at y808C for various time periods before total
RNA was isolated as described by Chomczynski and
w xSacchi 20 . Average RNA yields were 100–150
mgr107 cells as determined by measuring optical
density at 260 nm.
2.4. Labelling cDNA probes
The three different rat CaM cDNA probes and the
internal standard probe L17A were radiolabelled by
the random oligo-labelling procedure and separated
from free radioactivity by passage over a Sephadex
G-50 column equilibrated with 20 mM Tris-HCl pH
7.5, containing 20 mM EDTA and 0.25% SDS. Spe-
cific activities of all radiolabelled probes were 1–2=
109 dpmrmg.
2.5. Hybridisation and signal detection
 .Equal amounts of total RNA 20 mg from differ-
ent rat fibroblast cell lines were run on horizontal
 .gels containing 1.4% wrv agarose and 6% formal-
dehyde followed by transfer onto Biodyne A mem-
branes as described by the manufacturer. Blots were
w32 xhybridised to P -labelled cDNA in Rapid-hyb solu-
 .tion Amersham, Zurich, Switzerland and washed at¨
688C, 0.1=SSCr0.1% SDS twice for 15 min. Au-
toradiography was performed at y808C using Kodak
X-AR films with two screens. Signals on the blots
were quantitated on a PhosphorImager Molecular
.Dynamics, USA using the L17A signal which has a
molecular weight of 0.6 kb. Values are given as
ratios of signal intensities of CaM mRNA to L17A
mRNA.
2.6. Extraction and quantitation of total protein
Cells from different fibroblast lines were extracted
w xas described 21 . Total protein was determined by
w xthe Micro-Biuret method 22 .
2.7. Radioimmunoassay for CaM
CaM was quantitated by the NEN RIA kit DU
.PONT . The limit of detection was approximately 15
pg.
2.8. Labelling of CaM and o˝erlay assay.
w32 xGeneration of the P -labelled GST-CaM fusion
protein and detection of CaM binding proteins was
w xdone as reported 23 . Proteins were extracted from
the cells with lysate buffer 10 mM imidazole pH 7, 1
mM EGTA, 1 mM b-mercaptoethanol, 10 mM
MgCl , 150 mM NaCl, 0.5% Triton X-100, 2 mg2
.leupeptinrml, 10 mg aprotininrml . To obtain super-
natant and pellet fractions, the lysates were cen-
trifuged at 12 000=g, 48C for 5 min.
3. Results and discussion
3.1. Effect of PKC and oncogenes on CaM mRNA
le˝els
To analyse the mRNA levels generated by the
three CaM genes, three different CaM probes that
specifically recognise CaMI, CaMII and CaMIII genes
were used. Quantitation of Northern blots carried out
under stringent hybridisation conditions with equal
amounts of cytoplasmic RNA isolated from the con-
trol R6-C1 cell line and cells stably transfected with
the PKC cDNA and different oncogenes is shownb I
in Fig. 1. CaM I, CaM II and CaM III cDNA probes
hybridise to bands of 1.7 kb, 1.4 kb and 2.2 kb,
respectively, which were detected in all cells. The
sizes of these major CaM mRNA species are consis-
tent with those previously reported for rat CaM
w xmRNA 27 . Additional bands at 4.0 kb and 0.8 kb
can be attributed to the CaMI and the CaMIII genes,
respectively. Signal intensities among the different
major transcripts varied in rat embryo fibroblasts
transfected with PKC and various oncogenes mea-b I
sured as ratios to the signal intensity of L17A ribo-
.somal protein transcripts. PKC, oncogenes and com-
binations significantly decreased CaMI and CaMII
mRNA levels in most of the transfected cell lines
based on pairwise comparison with the untransfected
cell line in a student’s t-test. CaM I mRNA levels
were significantly downregulated in all transformed
cell lines except for cells transfected with neuN. CaM
II mRNA was decreased in all transformed cell lines
as compared to R6-C1. The cell lines transformed
with the T24 ras oncogene showed especially low
 .CaM II transcript levels 7% of control levels . CaM
III mRNA levels were significantly decreased in R6-
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 .T24 ras, R6-PKC T24 ras and R6-PKC myc cs
cells.
Three expressed CaM genes have been cloned
w xfrom the rat 10 . CaMI has a TATA box and CG
boxes in its 5X flanking region while CaMIII has only
CG boxes. The CaMII gene has a TATA-like box,
CG boxes, 2 CRE sequences and an AP2 binding
site. Until now no experimental data exists indicating
how the CaM genes are regulated during prolifera-
tion. A synergistic effect of the PKC and Ca2q
signalling pathways for the induction of the expres-
sion of the three CaM genes in NRK cells has been
w xreported 24 . Although PKC seems to be responsible
for the increase of CaM transcripts in NRK cells,
which is in contrast to the results reported in this
study, the synergistic effect of TPA plus ionomycin
 2q .indicates that another messenger Ca -dependent
could be involved in the regulation of the expression
w xof the CaM genes 24 . Our results differ also from a
w xprevious report by Rasmussen and Means 25 who
found that CaM mRNA levels were elevated in virus
transformed cells. Reasons for these discrepancies
may be that the cells in our experiments are of a
different origin or they have been initially trans-
formed by viruses for immortalization and addition-
ally transfected with PKC and different oncogenes.
Additionally, concerning the study of Bosch et al.
w x24 results obtained by pharmacologically activated
or inactivated endogenous PKC may differ form those
obtained by overexpression of one PKC isoform.
3.2. Effect of PKC and oncogenes on CaM le˝els
To evaluate whether the decreased level of CaM
mRNA is reflected at the protein level, we measured
the CaM concentration in the soluble fraction of the
different cell lines. The CaM protein levels were
found to be increased in the cell lines transfected
either with PKC or different oncogenes as compared
 .to the control cell line R6-C1 Fig. 2 . An increase in
CaM protein expression has been previously shown
to follow virally induced transformation of cells.
Whereas CaMIII transcription appeared to be unaf-
fected by transformation, both CaMI and CaMII tran-
scripts were increased in comparison to normal rat
 .kidney NRK cells or to normal kidney tissue con-
Fig. 1. Levels of CaM mRNAs in PKC and different oncogene transfected cell lines. Total RNA was extracted from the control and
oncogene transformed cells and analysed by Northern blot using specific CaMI, CaMII and CaMIII, or L17A probes. The blots were
quantified by PhosphorImager analysis. Ratios of signal intensities of CaM transcripts to ribosomal protein L17A transcripts were
calculated. Averages of three independent experiments with standard deviations are given except for CaMI in R6-PKC src, R6-neuT,
R6-PKC fos4 and R6-T24 ras cells, CaMII in R6-neuN cells and CaMIII in R6-neuN cells were only two values were averaged.
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Fig. 2. CaM protein content measured by RIA in PKC and
different oncogene transfected cell lines. Values are averages of
three independent experiments except for R6-PKC myc3, R6-PKC
 .fos 4, and R6-PKC mys cs cells were only two values were
averaged.
w xtrol 11 . In line with our finding that CaM mRNA
levels are lower in transformed cells as compared to
nontransformed counterparts is the observation that
half live of CaM mRNA in proliferating cells is
w xshorter than in quiescent or differentiated cells 26,27 .
The CaM protein levels in transformed cell lines
transfected with a combination of PKC with various
oncogenes is higher than that of cell lines trans-
formed by the corresponding oncogenes only. The
highest level of CaM was found in R6-PKC fos 4
 .cells 0.8 mgrmg . This is about 2-fold higher than
in the control cell line R6-C1.
Our finding that transformed cell lines contain
reduced CaM mRNA levels but increased protein
amounts suggests that post-transcriptional regulatory
mechanisms such as increased translation efficiency
andror protein stability are involved in the control of
CaM levels. Along this line, posttranslational modifi-
 .cation of CaM methylation or phosphorylation might
stabilize CaM. Additionally the subcellular location
of this protein or its interaction with target proteins
might affect its half-life. Posttranscriptional regula-
tion of CaM has also been reported by Colomer et al.
w x28 . They found that the levels of total CaM protein
in lymphoblastoid cell lines do not directly reflect the
levels of mRNA, since the different cell lines show
large differences in CaM mRNA content, whereas
CaM concentrations are very similar. Data from dif-
ferent laboratories indicate that CaM levels are higher
in transformed and rapidly dividing normal cells and
tissues than in their quiescent normal counterparts
w x11,13,29,30 . This suggest a positive correlation be-
tween CaM level and speed of cell cycle progression.
Other studies indicate that transcriptional regulation
of CaM genes is not the main mechanism by which
the critically important CaM levels are adjusted. CaM
concentration is progressively increasing from quies-
cent cells at 1.5 ngrmg protein to 3.0 ngrmg protein
w xduring S phase and mitosis in NRK cells 24 . In
another study the CaM synthetic rate was found to be
increased about 2-fold at the G1rS boundary com-
w xpared to G1 31 . However, the levels of CaM II
mRNA were maximal at M phase and decreased to a
minimum at the G1rS boundary in C-127 cells.
Furthermore, when quiescent Aspergillus spores were
stimulated to enter the cell cycle, CaM mRNA in-
creased nearly 20-fold, peaking at the start of S phase
and then decreasing by half as cells progressed
w xthrough S and G2rM 32 . In contrast, CaM protein
levels increased only 2-fold before the onset of S
phase and a further 2-fold increase coincided with the
entry into mitosis. Certainly most important would
now be to dissect mechanism of CaM upregulation
described in this contribution as well as in earlier
reports by others.
3.3. Effect of PKC and oncogenes on CaM binding
proteins le˝els
In order to identify fluctuations of the CaM bind-
ing proteins in the supernatants and the pellets of the
cell lysates of cell lines transfected with oncogenes in
combination with gene for protein kinase C, we
carried out CaM overlay experiments using a newly
w32 x w xdeveloped P -labelled GST-CaM probe 23 . Fig. 3
shows the CaM binding proteins of the supernatants
of the control cell line R6-C1 and of the different
oncogene transformed cell lines. As seen in Fig. 3A,
11 major CaM-binding proteins showing molecular
masses of 240, 200, 120, 60, 55, 52, 45, 34, 30, 28
and 26 kDa and several minor bands were present in
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the supernatants of the control R6-C1 cell line first
.  .lane . All these proteins except the 200 kDa band
bind CaM in a Ca2q dependent way. A similar
pattern can be observed in the cell lines transfected
with PKC and different oncogenes indicating that
CaM overexpressing cell lines do not generally over-
express CaM targets or affect their synthesis to a
major extent. A few additional protein bands could
however be observed in oncogene transformed cells.
A band at 110 kDa is induced by src and ras transfor-
mation and a band of approximately 40 kDa seems to
be specifically induced by fos transformation. The
intensity of the 240 kDa protein band was generally
much lower in all oncogene transformed cell line.
The intensity of the 60, 55, 45 and 34 kDa band was
on the other hand somewhat higher in NeuT, NeuN
and PKCrfos3 and PKCrfos4 oncogene transformed
cell lines. Synthesis of the latter proteins seems to be
specifically enhanced by Neu and fos oncogene trans-
formation. Except for the 200 kDa band which most
likely represents a myosin related protein we could
not detect any proteins in the supernatant of these cell
lines that bind CaM in the absence of Ca2q.
We next looked for CaM binding proteins in the
insoluble fraction. As shown in Fig. 4 the ratio
among the different CaM binding proteins from the
cell pellets was not significantly different among the
control R6-C1 and oncogene transformed cell line
although it seems that some cell lines exhibit differ-
ent levels of CaM binding protein in the pellet frac-
tion. This is most likely due to non-equal gel loading
since protein determination in the pellet fraction was
not possible because pellets had to be directly dis-
solved in SDS containing gel loading buffer Fig.
.4A . All the analysed cell lines expressed the CaM
binding proteins of molecular weight 60, 35, 34 and
30 kDa in the pellet fraction. The intensity of the 60
kDa band seemed to vary mostly with respect to the
intensity of the other bands. Only the band of 40 kDa
was clearly visible in some cell lines under Ca2q free
condition.
There are indications that the biosynthesis of CaM
and CaM binding proteins are coupled. One example
is that perturbation in CaM in v-src transformed cells
is paralleled by perturbation in certain CaM binding
proteins, including MLCK. The levels of MLCK-
Fig. 3. Expression of CaM-binding proteins monitored in the supernatant of cellular lysates of rat cell lines transfected with PKC and
 . 2q  .  .  .different oncogenes a . In the presence of Ca 1 mM . b In the presence of EGTA 5 mM . Arrows indicate protein bands discussed
in the text.
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Fig. 4. Expression of calmodulin-binding proteins monitored in the pellets of cellular lysates of rat cell lines transfected with PKC and
 . 2q  .  .  .different oncogenes a . In the presence of Ca 1 mM . b In the presence of EGTA 5 mM .
specific mRNA and protein in transformed chicken
 .embryonic fibroblast cell line CEF are approxi-
mately 2-fold lower as compared to normal CEFs
w x13 . A second example is the decrease in the level of
the CaM binding protein, phosphorylase kinase, which
is accompanied by a concomitant decrease in the
w xtissue level of CaM in the IrLyn mouse 33,34 .
The identity of the CaM binding proteins specifi-
cally affected by PKC or oncogene transformation
remains to be determined. Work designed to charac-
terise these proteins which might lead to an elucida-
tion of growth and cell cycle regulation by CaM is
under way in our laboratory.
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